Literature DB >> 21750410

Tet1 and 5-hydroxymethylation: a genome-wide view in mouse embryonic stem cells.

Hao Wu1, Yi Zhang.   

Abstract

Inner cell mass (ICM) cells of a blastocyst, the source of embryonic stem (ES) cells, are characterized by their unique ability to give rise to all cell types in adult organisms. The epigenomes of germ cells and developing zygotes undergo extensive reprogramming to acquire such a pluripotent state. A major reprogramming event during early embryonic development is the erasure and subsequent re-establishment of patterns of methylation at the 5-position of cytosine (5mC). The recent demonstration that Ten-eleven translocation family proteins, Tet1-3 have the capacity to convert 5mC to 5-hydroxymethylcytosine (5hmC) raises the possibility that 5hmC may act as an distinct epigenetic state contributing to dynamic changes in DNA methylation and transcriptional regulation during embryonic development. In ES cells, Tet1 is highly expressed and 5hmC is present at relatively high levels compared to most differentiated cells, but the functional significance of Tet1 and 5hmC in these pluripotent cells are not clear. Recently, a flurry of papers that profile the distribution of Tet1 and/or 5hmC across the genome of mouse ES cells provide new insights into the role of Tet proteins and 5hmC in regulating expression of genes related to pluripotency and cellular differentiation. Through integrative analyses of datasets from different groups, we reveal the common Tet1 and 5hmC targets in undifferentiated mouse ES cells, which suggest that Tet1 may play a key role in orchestrating the balance between pluripotent and lineage committed states.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21750410      PMCID: PMC3180185          DOI: 10.4161/cc.10.15.16930

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  34 in total

1.  Role of histone H3 lysine 27 methylation in Polycomb-group silencing.

Authors:  Ru Cao; Liangjun Wang; Hengbin Wang; Li Xia; Hediye Erdjument-Bromage; Paul Tempst; Richard S Jones; Yi Zhang
Journal:  Science       Date:  2002-09-26       Impact factor: 47.728

2.  Frequent switching of Polycomb repressive marks and DNA hypermethylation in the PC3 prostate cancer cell line.

Authors:  Einav Nili Gal-Yam; Gerda Egger; Leo Iniguez; Heather Holster; Steingrímur Einarsson; Xinmin Zhang; Joy C Lin; Gangning Liang; Peter A Jones; Amos Tanay
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-27       Impact factor: 11.205

3.  Promoter CpG methylation contributes to ES cell gene regulation in parallel with Oct4/Nanog, PcG complex, and histone H3 K4/K27 trimethylation.

Authors:  Shaun D Fouse; Yin Shen; Matteo Pellegrini; Steve Cole; Alexander Meissner; Leander Van Neste; Rudolf Jaenisch; Guoping Fan
Journal:  Cell Stem Cell       Date:  2008-02-07       Impact factor: 24.633

4.  Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1.

Authors:  Mamta Tahiliani; Kian Peng Koh; Yinghua Shen; William A Pastor; Hozefa Bandukwala; Yevgeny Brudno; Suneet Agarwal; Lakshminarayan M Iyer; David R Liu; L Aravind; Anjana Rao
Journal:  Science       Date:  2009-04-16       Impact factor: 47.728

5.  Acquired mutations in TET2 are common in myelodysplastic syndromes.

Authors:  Saskia M C Langemeijer; Roland P Kuiper; Marieke Berends; Ruth Knops; Mariam G Aslanyan; Marion Massop; Ellen Stevens-Linders; Patricia van Hoogen; Ad Geurts van Kessel; Reinier A P Raymakers; Eveline J Kamping; Gregor E Verhoef; Estelle Verburgh; Anne Hagemeijer; Peter Vandenberghe; Theo de Witte; Bert A van der Reijden; Joop H Jansen
Journal:  Nat Genet       Date:  2009-05-31       Impact factor: 38.330

6.  Mutation in TET2 in myeloid cancers.

Authors:  François Delhommeau; Sabrina Dupont; Véronique Della Valle; Chloé James; Severine Trannoy; Aline Massé; Olivier Kosmider; Jean-Pierre Le Couedic; Fabienne Robert; Antonio Alberdi; Yann Lécluse; Isabelle Plo; François J Dreyfus; Christophe Marzac; Nicole Casadevall; Catherine Lacombe; Serge P Romana; Philippe Dessen; Jean Soulier; Franck Viguié; Michaela Fontenay; William Vainchenker; Olivier A Bernard
Journal:  N Engl J Med       Date:  2009-05-28       Impact factor: 91.245

Review 7.  Epigenetic events in mammalian germ-cell development: reprogramming and beyond.

Authors:  Hiroyuki Sasaki; Yasuhisa Matsui
Journal:  Nat Rev Genet       Date:  2008-02       Impact factor: 53.242

8.  Prediction of novel families of enzymes involved in oxidative and other complex modifications of bases in nucleic acids.

Authors:  Lakshminarayan M Iyer; Mamta Tahiliani; Anjana Rao; L Aravind
Journal:  Cell Cycle       Date:  2009-06-27       Impact factor: 4.534

9.  A novel method for the efficient and selective identification of 5-hydroxymethylcytosine in genomic DNA.

Authors:  Adam B Robertson; John A Dahl; Cathrine B Vågbø; Pankaj Tripathi; Hans E Krokan; Arne Klungland
Journal:  Nucleic Acids Res       Date:  2011-02-07       Impact factor: 16.971

10.  The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain.

Authors:  Skirmantas Kriaucionis; Nathaniel Heintz
Journal:  Science       Date:  2009-04-16       Impact factor: 47.728

View more
  71 in total

1.  Genome-wide mapping of 5-hydroxymethylcytosine in three rice cultivars reveals its preferential localization in transcriptionally silent transposable element genes.

Authors:  Xi-liang Wang; Shu-hui Song; Yong-Sheng Wu; Yu-Li Li; Ting-ting Chen; Zhi-yuan Huang; Shuo Liu; Thomas L Dunwell; Gerd P Pfeifer; Jim M Dunwell; Raheema Wamaedeesa; Ihsan Ullah; Yinsheng Wang; Song-nian Hu
Journal:  J Exp Bot       Date:  2015-08-13       Impact factor: 6.992

2.  Methylcytosine dioxygenase TET3 interacts with thyroid hormone nuclear receptors and stabilizes their association to chromatin.

Authors:  Wenyue Guan; Romain Guyot; Jacques Samarut; Frédéric Flamant; Jiemin Wong; Karine Cécile Gauthier
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-17       Impact factor: 11.205

3.  Fam60a defines a variant Sin3a-Hdac complex in embryonic stem cells required for self-renewal.

Authors:  Gundula Streubel; Darren J Fitzpatrick; Giorgio Oliviero; Andrea Scelfo; Bruce Moran; Sudipto Das; Nayla Munawar; Ariane Watson; Kieran Wynne; Gian Luca Negri; Eugene T Dillon; SriGanesh Jammula; Karsten Hokamp; Darran P O'Connor; Diego Pasini; Gerard Cagney; Adrian P Bracken
Journal:  EMBO J       Date:  2017-05-29       Impact factor: 11.598

Review 4.  Common stemness regulators of embryonic and cancer stem cells.

Authors:  Christiana Hadjimichael; Konstantina Chanoumidou; Natalia Papadopoulou; Panagiota Arampatzi; Joseph Papamatheakis; Androniki Kretsovali
Journal:  World J Stem Cells       Date:  2015-10-26       Impact factor: 5.326

Review 5.  Somatic alterations and dysregulation of epigenetic modifiers in cancers.

Authors:  Shlomzion Aumann; Omar Abdel-Wahab
Journal:  Biochem Biophys Res Commun       Date:  2014-08-09       Impact factor: 3.575

Review 6.  DNA methylation and methylcytosine oxidation in cell fate decisions.

Authors:  Kian Peng Koh; Anjana Rao
Journal:  Curr Opin Cell Biol       Date:  2013-03-14       Impact factor: 8.382

Review 7.  5-Hydroxymethylcytosine: generation, fate, and genomic distribution.

Authors:  Li Shen; Yi Zhang
Journal:  Curr Opin Cell Biol       Date:  2013-03-13       Impact factor: 8.382

Review 8.  5-Hydroxymethylcytosine--the elusive epigenetic mark in mammalian DNA.

Authors:  Edita Kriukienė; Zita Liutkevičiūtė; Saulius Klimašauskas
Journal:  Chem Soc Rev       Date:  2012-07-27       Impact factor: 54.564

Review 9.  Epigenetic Determinants of Cancer.

Authors:  Stephen B Baylin; Peter A Jones
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-09-01       Impact factor: 10.005

10.  HMGA2/TET1/HOXA9 signaling pathway regulates breast cancer growth and metastasis.

Authors:  Miao Sun; Chun-Xiao Song; Hao Huang; Casey A Frankenberger; Devipriya Sankarasharma; Suzana Gomes; Ping Chen; Jianjun Chen; Kiran K Chada; Chuan He; Marsha R Rosner
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.